In patients with HIV infection, highly active antiretroviral therapy is improving survival, but at the price of a variety of metabolic side effects. Patterns of morbidity and mortality are changing: the leading cause of death is now kidney or liver failure instead of opportunistic infections.
No takes yet. Share an insight, caveat, or question.
A 2001 study studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: